title: [Evaluation of amyxin effect in prophylaxis of acute respiratory viral infections].
abstract: The results of the evaluation of the oral inductor of endogenic interferon (amyxin), manufactured in Russia are presented. The use of amyxin was found to produce a drop in morbidity in acute respiratory virus infections (ARVI) among medical workers 3.4 times, i.e. the preparation exhibited a pronounced prophylactic effect with respect to ARVI. The use of the preparation was accompanied by a decrease in the number of manifest forms of ARVI. Persons given the preparation often had ARVI in a mild or asymptomatic form.
authors.affiliation: Botkin City Clinical Hospital, Gamaleya Research Institute of Epidemiology and Mikrobiology, Medical Academy of Post-Diploma Education, Central State Sanitary and Epidemiological Inspection, Moscow, Russia.
authors.forename: E P
authors.initials: EP
authors.lastname: Sel'kova
authors.forename: V N
authors.initials: VN
authors.lastname: Iakovlev
authors.forename: T A
authors.initials: TA
authors.lastname: Semenenko
authors.forename: N N
authors.initials: NN
authors.lastname: Filatov
authors.forename: T P
authors.initials: TP
authors.lastname: Gotvianskaia
authors.forename: G A
authors.initials: GA
authors.lastname: Danilina
authors.forename: T N
authors.initials: TN
authors.lastname: Pantiukhova
authors.forename: G Iu
authors.initials: GIu
authors.lastname: Nikitina
authors.forename: M Kh
authors.initials: MKh
authors.lastname: Tur'ianov
mesh_terms: D000208:Acute Disease; D006801:Humans; D007369:Interferon Inducers / Q000627:therapeutic use*; D009031:Moscow / Q000453:epidemiology; D012141:Respiratory Tract Infections / Q000453:epidemiology / Q000517:prevention & control*; D013994:Tilorone / Q000627:therapeutic use*; D014777:Virus Diseases / Q000453:epidemiology / Q000517:prevention & control*
chemical_list: D007369:Interferon Inducers; D013994:Tilorone